StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Dare Bioscience's operating income for the twelve months ending Jun 30, 2026 was -$11.11M. For fiscal 2025 it was -$13.55M. The highest annual figure on record is -$630.59K in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.55M–
FY2024Dec 31, 2024-$23.45M–
FY2023Dec 31, 2023-$30.94M–
FY2022Dec 31, 2022-$31.39M–
FY2021Dec 31, 2021-$39.07M–
FY2020Dec 31, 2020-$27.40M–
FY2019Dec 31, 2019-$14.34M–
FY2018Dec 31, 2018-$16.88M–
FY2017Dec 31, 2017-$11.18M–
FY2016Dec 31, 2016-$630.59K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.97M–
Q1 FY2026Mar 31, 2026-$3.00M–
Q4 FY2025Dec 31, 2025-$1.47M–
Q3 FY2025Sep 30, 2025-$3.67M–
Q2 FY2025Jun 30, 2025-$3.83M–
Q1 FY2025Mar 31, 2025-$4.58M–
Q4 FY2024Dec 31, 2024-$5.39M–
Q3 FY2024Sep 30, 2024-$4.68M–
Q2 FY2024Jun 30, 2024-$7.36M–
Q1 FY2024Mar 31, 2024-$6.02M–
Q4 FY2023Dec 31, 2023-$5.17M–
Q3 FY2023Sep 30, 2023-$8.40M–
Q2 FY2023Jun 30, 2023-$8.99M-2439.0%
Q1 FY2023Mar 31, 2023-$8.38M–
Q4 FY2022Dec 31, 2022-$16.23M–
Q3 FY2022Sep 30, 2022-$7.14M–
Q2 FY2022Jun 30, 2022$384.32K–
Q1 FY2022Mar 31, 2022-$8.40M–
Q4 FY2021Dec 31, 2021-$9.54M–
Q3 FY2021Sep 30, 2021-$12.67M–
Q2 FY2021Jun 30, 2021-$9.16M–
Q1 FY2021Mar 31, 2021-$7.69M–
Q4 FY2020Dec 31, 2020-$8.44M–
Q3 FY2020Sep 30, 2020-$7.58M–
Q2 FY2020Jun 30, 2020-$7.13M–
Q1 FY2020Mar 31, 2020-$4.25M–
Q4 FY2019Dec 31, 2019-$3.86M–
Q3 FY2019Sep 30, 2019-$3.42M–
Q2 FY2019Jun 30, 2019-$3.98M–
Q1 FY2019Mar 31, 2019-$3.08M–
Q4 FY2018Dec 31, 2018-$2.96M–
Q3 FY2018Sep 30, 2018-$2.62M–
Q2 FY2018Jun 30, 2018-$3.62M–
Q1 FY2018Mar 31, 2018-$7.68M–
Q4 FY2017Dec 31, 2017-$9.14M–
Q3 FY2017Sep 30, 2017-$1.33M–
Q2 FY2017Jun 30, 2017-$479.62K–
Q1 FY2017Mar 31, 2017-$228.46K–
Q4 FY2016Dec 31, 2016-$188.64K–
Q3 FY2016Sep 30, 2016-$5.96K–

More Dare Bioscience figures

See a number that looks wrong?